Katyayini Tissues Profile
Key Indicators
- Authorised Capital ₹ 4.48 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.48 Cr
as on 24-10-2024
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.72 Cr
as on 24-10-2024
- Satisfied Charges ₹ 9.05 Cr
as on 24-10-2024
- Revenue 1146.43%
(FY 2023)
- Profit 7489.18%
(FY 2023)
- Ebitda 678.20%
(FY 2023)
- Net Worth 29.95%
(FY 2023)
- Total Assets 27.77%
(FY 2023)
About Katyayini Tissues
The Corporate was formerly known as B.R. Papers Private Limited. The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.48 Cr and a paid-up capital of Rs 4.48 Cr.
The company currently has active open charges totaling ₹10.72 Cr. The company has closed loans amounting to ₹9.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Digansh Agarwal, Deepika Agarwal, Arnav Sharma, and Two other members serve as directors at the Company.
- CIN/LLPIN
U21098UR2008PTC032568
- Company No.
032568
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Udham Singh Nagar, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Katyayini Tissues?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Digansh Agarwal  | Director | 30-Sep-2019 | Current |
| Deepika Agarwal | Director | 30-Sep-2019 | Current |
| Arnav Sharma | Director | 28-Nov-2022 | Current |
| Sweta Sharma | Director | 28-Nov-2022 | Current |
| Pallavi Tyagi | Additional Director | 08-Jun-2024 | Current |
Financial Performance of Katyayini Tissues.
Katyayini Tissues Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1146.43% increase. The company also saw a substantial improvement in profitability, with a 7489.18% increase in profit. The company's net worth Soared by an impressive increase of 29.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Katyayini Tissues?
In 2023, Katyayini Tissues had a promoter holding of 20.90% and a public holding of 79.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prolific Papers Private LimitedActive 17 years 10 monthsDigansh Agarwal and Deepika Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 24 Jan 2024 | ₹3.20 M | Open |
Uco Bank Creation Date: 27 Sep 2023 | ₹2.45 M | Open |
Uco Bank Creation Date: 30 Mar 2021 | ₹10.15 Cr | Open |
How Many Employees Work at Katyayini Tissues?
Katyayini Tissues has a workforce of 12 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Katyayini Tissues, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Katyayini Tissues's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
